Edition:
United States

People: Arrowhead Pharmaceuticals Inc (ARWR.OQ)

ARWR.OQ on NASDAQ Stock Exchange Global Select Market

14.32USD
14 Dec 2018
Change (% chg)

$-0.48 (-3.24%)
Prev Close
$14.80
Open
$14.69
Day's High
$15.05
Day's Low
$14.26
Volume
463,091
Avg. Vol
654,561
52-wk High
$22.38
52-wk Low
$3.06

Frykman, Edward 

Mr. Edward W. Frykman is an Independent Director of Arrowhead Pharmaceuticals Inc. Mr. Frykman was an Account Executive with Crowell, Weedon & Co., a position he held from 1992 until 2008 when he retired. Before his service at Crowell, Weedon & Co., Mr. Frykman served as Senior Vice President of L.H. Friend & Co. Both Crowell Weedon & Co. and L.H. Friend & Co. are investment brokerage firms located in Southern California. In addition, Mr. Frykman was a Senior Account Executive with Shearson Lehman Hutton, where he served as the Manager of the Los Angeles Regional Retail Office of E. F. Hutton & Co. Mr. Frykman is also a director of Acacia Research Corporation, a publicly-held corporation based in Newport Beach, California. Mr. Frykman’s qualifications to serve on the Board include his long tenure as a member of the Board, which has enabled Mr. Frykman to gain a deep

Basic Compensation

Total Annual Compensation, USD 51,875
Restricted Stock Awards, USD 77,500
Long-Term Incentive Plans, USD --
All Other, USD --
Fiscal Year Total, USD 129,375

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Douglass Given

201,813

Christopher Anzalone

1,871,210

Kenneth Myszkowski

725,371

Bruce Given

1,384,190

Zhen Li

--

Patrick O'Brien

804,990
As Of  29 Sep 2017